|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| (11) | Number of the document | 2370466 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09795723.7 |
| Date of filing the European patent application | 2009-12-21 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-06 |
| (46) | Date of publication of the claims translation | 2015-10-26 |
| (86) | Number | PCT/EP2009/009186 |
| Date | 2009-12-21 |
| (87) | Number | WO 2010/069603 |
| Date | 2010-06-24 |
| (30) | Number | Date | Country code |
| 08022188 | 2008-12-19 | EP | |
| 139253 P | 2008-12-19 | US |
| (72) |
WEIHOFEN, Andreas, CH
GRIMM, Jan, CH
NITSCH, Roger, CH
HOCK, Christoph, CH
|
| (73) |
Biogen International Neuroscience GmbH,
Landis + Gyr-Strasse 3, 6300 Zug,
CH
University of Zurich, Prorektorat Forschung Rämistrasse 71, 8006 Zurich, CH |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žmogaus anti-alfa-sinukleino autoantikūnai |
| HUMAN ANTI-ALPHA-SYNUCLEIN AUTOANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-05-30 | 15 | 433.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-12-21 |